piggyBac transposon-mediated CAR-T cell therapy targeting EPHB4 exhibited sufficient CAR positivity, stable CAR expression, a favorable phenotype, and strong antitumor efficacy against EPHB4-positive tumors and would be promising for the treatment of malignant rhabdomyosarcomas. The gene discussed is EPHB4; the disease is rhabdomyosarcoma.